BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $556,514 | -14.2% | 14,746 | +3.6% | 0.00% | 0.0% |
| Q2 2023 | $648,364 | +15.7% | 14,231 | +3.0% | 0.00% | 0.0% |
| Q1 2023 | $560,377 | +78715.3% | 13,816 | -1.0% | 0.00% | -33.3% |
| Q4 2022 | $711 | -99.9% | 13,953 | -3.0% | 0.00% | 0.0% |
| Q3 2022 | $774,000 | +115.6% | 14,379 | +157.2% | 0.00% | +200.0% |
| Q2 2022 | $359,000 | -21.6% | 5,590 | -5.4% | 0.00% | 0.0% |
| Q1 2022 | $458,000 | +39.6% | 5,908 | +54.4% | 0.00% | 0.0% |
| Q4 2021 | $328,000 | +4.1% | 3,826 | -2.3% | 0.00% | 0.0% |
| Q3 2021 | $315,000 | -68.7% | 3,915 | -66.5% | 0.00% | -83.3% |
| Q2 2020 | $1,005,000 | +6.0% | 11,674 | 0.0% | 0.01% | -25.0% |
| Q1 2020 | $948,000 | +18.4% | 11,674 | +21.9% | 0.01% | +60.0% |
| Q4 2019 | $801,000 | +79.6% | 9,578 | +87.8% | 0.01% | +66.7% |
| Q3 2019 | $446,000 | +0.9% | 5,100 | -5.6% | 0.00% | 0.0% |
| Q2 2019 | $442,000 | -2.9% | 5,400 | -3.6% | 0.00% | -25.0% |
| Q1 2019 | $455,000 | -31.6% | 5,600 | -44.6% | 0.00% | -50.0% |
| Q4 2018 | $665,000 | +90.5% | 10,101 | +123.0% | 0.01% | +166.7% |
| Q3 2018 | $349,000 | -50.4% | 4,530 | -52.5% | 0.00% | -62.5% |
| Q2 2018 | $704,000 | -77.1% | 9,528 | -79.8% | 0.01% | -80.0% |
| Q1 2018 | $3,073,000 | +6.7% | 47,249 | +6.1% | 0.04% | +33.3% |
| Q4 2017 | $2,879,000 | +127.6% | 44,538 | +120.9% | 0.03% | +150.0% |
| Q3 2017 | $1,265,000 | -33.6% | 20,164 | -35.9% | 0.01% | -70.7% |
| Q2 2017 | $1,904,000 | +44.8% | 31,452 | +24.1% | 0.04% | +46.4% |
| Q1 2017 | $1,315,000 | +0.2% | 25,353 | -14.3% | 0.03% | +16.7% |
| Q4 2016 | $1,312,000 | – | 29,581 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |